Pioglitazone-containing Medicines: Drug Safety Communication

Includes Actos, Actoplus Met, Actoplus Met XR, Duetact, and Oseni [Posted 12/12/2016] AUDIENCE: Internal Medicine, Endocrinology, Urology ISSUE: As a result of an updated review, the FDA has concluded that use of the type 2 diabetes medicine pioglitazone (Actos, Actoplus Met, Actoplus Met XR, Duetact, Oseni) may be linked to an increased risk of bladder…

Class I Medical Device Recall: Centurion Recalls Multi-Med Single Lumen Catheters due to Excess Material that May Split or Separate

<!– –> <!– Page Last Updated: 12/09/2016 –> Page Last Updated: 12/09/2016 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players. Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français |…

Emergency Use Authorizations: Zika ELITe MGB® Kit U.S. (ELITechGroup Inc. Molecular Diagnostics)

On February 26, 2016, the FDA issued an Emergency Use Authorization (EUA) to authorize the emergency use of Centers for Disease Control and Prevention’s (CDC) Zika Immunoglobulin M (IgM) Antibody Capture Enzyme-Linked Immunosorbent Assay (Zika MAC-ELISA) for the presumptive detection of Zika virus-specific IgM in human sera or cerebrospinal fluid (CSF) that is submitted alongside…

MDUFA III Performance Report

%PDF-1.7% 55216 0 objendobj 55238 0 obj/Filter/FlateDecode/ID[]/Index[55216 59]/Info 55215 0 R/Length 113/Prev 3262507/Root 55217 0 R/Size 55275/Type/XRef/W[1 3 1]stream hbbd“`b`”oH^”$l8V “”V$c+]DrŀuI]0yD:_kə@BF`3 A@

Immediately in Effect Guidance Document: Conditions for Sale for Air-Conduction Hearing Aids

%PDF-1.7 % 369 0 obj stream xw`E UHyGS”WExyEx슾 R,+ * (ҫn;^~pO2}vv* BW_A[BP aB kBP aB kBP aB kBP ay%MO]K~suK5|iMhd+!Ѫt!-X8-)wˋed{51AWj]!jZTI?6y~ƢLKtJ%i158bxyNRU}nKE}~uHuuE6m;,IGA^_ύX},3m|-1o7!~MĘ2~Fy N[M#vw׊WC`”!Y1#3kb9Dy^Or)#}m獢Ϗ/kG*g[0?Ao.`RG0ۯIrʈW)L* LdP4Ύgd@vߛ ψ`RHA16J!9!IL{HvrʈW0?+,r[yAmx- nba#_DNY )ak$f9bVctZy-A!CFQgb6 FqeJLK?rjv+@q)ztDnx ucH۝YjPԇ^KxnLLQ/ʧ Yf7޷xlF6A^ڂWξswۻ:Ŝ~xyv~C s23Cst6x!im2u1Z~(jgNm7O2gedTz7yG:`LzuwJ!5